Clinical trial experts have contended that trial sites need to be located within communities to achieve diversity in study enrollment. Three universities are now moving forward with an initiative to establish a network of connected, sustainable, community-based trial sites that can enroll patients in studies sponsored by the pharmaceutical industry and others.
Clinical Trial Diversity: PhRMA, Academia Lay Foundation For Network Of Community-Based Sites
PhRMA is funding an initiative to establish a network of sustainable, community-based trial sites. During 18-month proof of concept phase, 10 sites will receive training, technical support and mentorship.
